Page last updated: 2024-08-24

celgosivir and ribavirin

celgosivir has been researched along with ribavirin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Behnam, MA; Boldescu, V; Klein, CD; Nitsche, C1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Ahmed, P; Patel, D; Taylor, D; Tyms, AS; Whitby, K1
Flamand, M; Liu, W; Schul, W; Vasudevan, SG; Xu, HY1
Durantel, D1

Reviews

2 review(s) available for celgosivir and ribavirin

ArticleYear
The Medicinal Chemistry of Dengue Virus.
    Journal of medicinal chemistry, 2016, 06-23, Volume: 59, Issue:12

    Topics: Antiviral Agents; Chemistry, Pharmaceutical; Dengue; Dengue Virus; Humans; Molecular Conformation; Structure-Activity Relationship

2016
Celgosivir, an alpha-glucosidase I inhibitor for the potential treatment of HCV infection.
    Current opinion in investigational drugs (London, England : 2000), 2009, Volume: 10, Issue:8

    Topics: alpha-Glucosidases; Animals; Antiviral Agents; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Glycoside Hydrolase Inhibitors; Hepacivirus; Hepatitis C, Chronic; Humans; Indolizines; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Prodrugs; Recombinant Proteins; Ribavirin

2009

Other Studies

3 other study(ies) available for celgosivir and ribavirin

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Action of celgosivir (6 O-butanoyl castanospermine) against the pestivirus BVDV: implications for the treatment of hepatitis C.
    Antiviral chemistry & chemotherapy, 2004, Volume: 15, Issue:3

    Topics: alpha-Glucosidases; Animals; Antiviral Agents; Bovine Virus Diarrhea-Mucosal Disease; Cattle; Cell Line; Cytopathogenic Effect, Viral; Diarrhea Viruses, Bovine Viral; Disease Models, Animal; Drug Synergism; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Hepacivirus; Hepatitis C; Humans; Indolizines; Inhibitory Concentration 50; Interferon-alpha; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Viral; Viral Envelope Proteins; Viral Plaque Assay

2004
A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs.
    The Journal of infectious diseases, 2007, Mar-01, Volume: 195, Issue:5

    Topics: 1-Deoxynojirimycin; Animals; Antiviral Agents; Dengue; Disease Models, Animal; Dose-Response Relationship, Drug; Indolizines; Mice; Ribavirin; Time Factors; Tubercidin; Viremia; Virus Replication

2007